Our partner in Israel

This report presents an analysis of the drug markets in the European Neighbourhood Policy-South region covering Algeria, Egypt, Israel, Jordan, Lebanon, Libya, Morocco, Palestine (*), Syria and Tunisia.

Between March and May 2021, the EU4Monitoring Drugs (EU4MD) project supported the mapping of national prevention systems in European Neighbourhood Policy (ENP) area countries.

Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to progressive introduction of social distancing and other control measures by national governments.

Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to the progressive introduction of social distancing and other control measures by national governments.

Follow the timeline and take a walk through some of the key moments in the EMCDDA's 25 years of international cooperation.

This summary was prepared in the framework of the EMCDDA technical cooperation project ‘Towards a gradual improvement of ENP partner countries’ capacity to monitor and to meet drug-related challenges’ (ENPI), funded by the European Commission.